Stay Updated
Press Releases
Pharma’s Losing Streak In Court Continues: Novo Nordisk’s Appeal Rejected
Bipartisan panel of judges unanimously rejects industry’s recycled arguments as lower drug prices draw closer for millions of patients WASHINGTON, D.C. — In yet another blow to Big Pharma’s nationwide legal campaign against Medicare Negotiation, the U.S. Court of Appeals For The Third Circuit unanimously rejected Novo Nordisk’s challenge to the program this morning — marking the 15th legal defeat for […]
Press Releases
Countering PhRMA’s legal claims, P4AD continues to defend the historic Medicare Negotiation Program by amplifying the experiences of patients with high drug prices. WASHINGTON, D.C. — Today, Patients For Affordable Drugs (P4AD) filed its fifth patient-centered amicus brief defending the Medicare Negotiation Program – this time in the Fifth Circuit Court of Appeals, where PhRMA […]
Press Releases
WASHINGTON, D.C. — AstraZeneca has petitioned the U.S. Supreme Court in a desperate attempt to overturn its 2024 loss in federal court and stop Medicare from negotiating lower drug prices for U.S. patients. The move marks an escalation of pharma’s nationwide legal campaign to preserve the industry’s monopoly pricing power, and would strip President Trump’s […]
Press Releases
Federal Court Rejects Novartis’s Case Against Medicare Negotiation
The unanimous decision marks the 14th ruling against Big Pharma and in favor of patients. WASHINGTON, D.C. — Today, the U.S. Court of Appeals For The Third Circuit unanimously rejected Novartis’ challenge to the Medicare Drug Price Negotiation Program, exactly one week after the same court delivered a similar defeat to Bristol Myers Squibb […]
Press Releases
Another Patient Victory: Federal Court Rejects BMS and Janssen’s Case Against Medicare Negotiation
WASHINGTON, D.C. — This morning, the U.S. Court of Appeals For The Third Circuit rejected Bristol Myers Squibb (BMS) and Janssen’s challenge to the Medicare Drug Price Negotiation Program, standing with patients and affirming the earlier district court decision that the program is constitutional. Following pharma’s three legal defeats in August, this latest decision marks the 13th ruling in favor of […]
Press Releases
ICYMI: Courts Deliver Three Major Legal Wins for Medicare Drug Price Negotiation in Just Two Days
WASHINGTON, D.C. — Over the span of just 48 hours, three federal courts delivered resounding defeats to Big Pharma’s legal campaign to overturn the Medicare Drug Price Negotiation Program — marking the 10th, 11th, and 12th rulings in favor of patients and the law that’s set to deliver lower drug prices to 9 million people on […]
Press Releases
The U.S. Court of Appeals for the Second Circuit stood with a lower court’s 2024 decision ruling against Boehringer Ingelheim WASHINGTON, D.C. — In yet another decisive win for patients, the U.S. Court of Appeals for the Second Circuit rejected Boehringer Ingelheim’s attempt to block Medicare’s authority to negotiate lower drug prices. This marks the second win in less than 24 […]
Press Releases
PHARMA DEFEAT: Federal Court Rejects U.S. Chamber of Commerce’s Case Against Medicare Negotiation
The U.S. Court of Appeals for the Sixth Circuit stood with the lower court’s 2024 decision to dismiss the U.S. Chamber of Commerce’s Case WASHINGTON, D.C. — In another blow to pharma’s multi-million dollar legal campaign against the Medicare Negotiation Program, today the Sixth Circuit U.S. Court of Appeals blocked a legal challenge to […]